|
ALLR
|
Allarity Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ANGN
|
Angion Biomedica Corp.
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
US
|
NASDAQ
|
|
COGT
|
Cogent Biosciences, Inc.
|
US
|
NASDAQ
|
|
EXEL
|
Exelixis, Inc.
|
US
|
NASDAQ
|
|
EYPT
|
EyePoint Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
KALA
|
Kala Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
KRON
|
Kronos Bio, Inc.
|
US
|
NASDAQ
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NVCT
|
Nuvectis Pharma, Inc.
|
US
|
NASDAQ
|
|
PBYI
|
Puma Biotechnology Inc
|
US
|
NASDAQ
|
|
RIGL
|
Rigel Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
RLAY
|
Relay Therapeutics, Inc.
|
US
|
NASDAQ
|
|
THRX
|
Theseus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ABSCF
|
Ab Science Paris
|
US
|
OTC
|
|
HMDCF
|
Hutchison China Ltd
|
US
|
OTC
|
|
REDX
|
Redx Pharma Plc
|
UK
|
LSE
|
|
SAR
|
Sareum Holdings Plc
|
UK
|
LSE
|
|
0013
|
HUTCHMED China Ltd
|
HK
|
HK
|